EU Novel Drug Approvals Climb In 2025: Early Expectations For 2026

perspectives 2026
The European Commission authorized 43 NAS-containing drugs in 2025, marking steady growth from 2024 (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approvals

More from Product Reviews